Corindus raises $25M to commercialize CorPath GRX surgical robot

Corindus Vascular Robotics inked a private placement deal worth $25 million through the offering of newly-designated Series A convertible preferred stock, with funds slated to support global commercialization of its CorPath GRX robotic surgical system. The Waltham, Mass.-based company will issue shares of Series A convertible preferred stock convertible into 20 million shares of common stock…

The post Corindus raises $25M to commercialize CorPath GRX surgical robot appeared first on The Robot Report.